Reduction of prostaglandin H synthase compound II by phenol and hydroquinone, and the effect of indomethacin.
The reduction of prostaglandin H synthase compound II to native enzyme by phenol and by hydroquinone, in the presence of diethyldithiocarbamate as a stabilizing agent, was studied by rapid scan spectrometry and transient state kinetics at 4.0 +/- 0.5 degrees C in 0.1 M phosphate buffer, pH 8.0. The plot of pseudo-first-order rate constants for the conversion of prostaglandin H synthase compound II to native enzyme versus phenol concentration was linear with a non-zero intercept. The second-order rate constant was determined from the slope to be (5.3 +/- 0.3) x 10(5) M-1 s-1. For the reduction by hydroquinone, the second-order rate constant was determined from pointwise measurements of the pseudo-first-order rate constant to be (2.1 +/- 0.4) x 10(6) M-1 s-1. Rapid scan spectrum results also showed the reduction of compound I to compound II by both phenol and hydroquinone. Thus reduction of both compound I and compound II is one electron process. Our results suggest that the tyrosyl radical, detected in the presence of oxidizing agents, is formed by intramolecular electron transfer from the tyrosyl residue to the porphyrin pi-cation radical, and this reaction tends to disappear in the presence of sufficient reducing substrate. These in vitro results support speculation that there is a role of the peroxidase component of prostaglandin H synthase in benzene-induced toxicity. In the present work, the effect of indomethacin on the reduction of prostaglandin H synthase compound II by diethyldithiocarbamate, phenol, and hydroquinone was also investigated. Results revealed, for the first time, that indomethacin is an inhibitor of the peroxidase activity of prostaglandin H synthase, although not as effectively as in its well-known inhibition of cyclooxygenase activity.
Hsuanyu
Y C
YC
Department of Chemistry, University of Alberta, Edmonton, Canada.
Dunford
H B
HB
D000818:Animals; D016861:Cyclooxygenase Inhibitors / Q000494:pharmacology; D006873:Hydroquinones / Q000494:pharmacology*; D007213:Indomethacin / Q000494:pharmacology*; D007700:Kinetics; D008297:Male; D010084:Oxidation-Reduction / Q000187:drug effects; D019800:Phenol; D010636:Phenols / Q000494:pharmacology*; D011451:Prostaglandin-Endoperoxide Synthases / Q000096:biosynthesis / Q000737:chemistry* / Q000187:drug effects; D012669:Seminal Vesicles / Q000201:enzymology; D012756:Sheep; D013379:Substrate Specificity
D016861:Cyclooxygenase Inhibitors; D006873:Hydroquinones; D010636:Phenols; D019800:Phenol; D011451:Prostaglandin-Endoperoxide Synthases; C031927:hydroquinone; D007213:Indomethacin